Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Clinical and Laboratory Evaluation of Acute Pericarditis Associated with Antinuclear Antibodies Positivity

Author(s): Ali Doğan Dursun, Ersin Saricam*, Hakan Erdem, Gulcin Turkmen Sariyildiz, Esref Umut Ozyer, Engin Bozkurt, Erdogan Ilkay and Ömer Faruk Cantekin

Volume 21, Issue 1, 2023

Published on: 16 February, 2023

Page: [51 - 58] Pages: 8

DOI: 10.2174/1570161121666230131122649

Price: $65

Abstract

Background: Up to 30% of patients with acute pericarditis develop recurrent pericarditis. Acute pericarditis may be a manifestation of an underlying systemic autoimmune disease. Therefore, we evaluated the characteristics of patients with acute pericarditis according to antinuclear antibodies (ANA) positivity/negativity.

Methods: Participants with acute pericarditis and negative ANA (n=29), recurrent pericarditis with positive ANA (n=30) and healthy controls (n=11) were examined. The groups were compared using serum parameters (ANA, C-reactive protein, leucocyte count, erythrocyte sedimentation rate, total antioxidant status, nitric oxide (NO), and oxidative stress index (OSI)) and imaging techniques (electrocardiogram, echocardiography, cardiovascular magnetic resonance, and venous Doppler ultrasound).

Results: In females, acute pericarditis associated with ANA occurred more frequently (p<0.001). ANApositive acute pericarditis had significantly lower NO and OSI (p<0.05 and p<0.001, respectively) and pericardial inflammation on magnetic resonance. We found a pulmonary embolism in one patient with positive ANA. Slow venous flow (SVF) occurred more often in acute pericarditis associated with ANA than in the ANA-negative group on venous ultrasound (p<0.05). The prevalence of positive ANAs was 1.6 times higher among SVF patients than in controls.

Conclusion: This study suggests that acute pericarditis associated with ANA is more common in middle- aged females. SVF and lower oxidative stress tests were more common in patients with ANAassociated acute pericarditis. Acute pericarditis associated with ANA could be considered as a hypercoagulable state. Therefore, all newly diagnosed pericarditis patients (especially females) should be checked for ANA positivity. Awareness of this coexistence should be promptly addressed to establish management strategies.

Keywords: Acute pericarditis, antinuclear antibodies positivity, female, oxidative stress, serum parameters, slow venous flow.

« Previous Next »
Graphical Abstract

[1]
Tonini M, Melo DTP, Fernandes F. Acute pericarditis. Rev Assoc Med Bras 2015; 61(2): 184-90.
[http://dx.doi.org/10.1590/1806-9282.61.02.184] [PMID: 26107370]
[2]
Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol 2012; 27(3): 308-17.
[http://dx.doi.org/10.1097/HCO.0b013e3283524fbe] [PMID: 22450720]
[3]
Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart 2015; 101(14): 1159-68.
[http://dx.doi.org/10.1136/heartjnl-2014-306362] [PMID: 25855795]
[4]
LeWinter MM. Acute pericarditis. N Engl J Med 2014; 371(25): 2410-6.
[http://dx.doi.org/10.1056/NEJMcp1404070] [PMID: 25517707]
[5]
Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J 2015; 36(42): 2921-64.
[http://dx.doi.org/10.1093/eurheartj/ehv318] [PMID: 26320112]
[6]
Imazio M, Brucato A, DeRosa FG, et al. Aetiological diagnosis in acute and recurrent pericarditis: When and how. J Cardiovasc Med (Hagerstown) 2009; 10(3): 217-30.
[http://dx.doi.org/10.2459/JCM.0b013e328322f9b1] [PMID: 19262208]
[7]
Assayag M, Abbas R, Chanson N, et al. Diagnosis of systemic inflammatory diseases among patients admitted for acute pericarditis with pericardial effusion. J Cardiovasc Med (Hagerstown) 2017; 18(11): 875-80.
[http://dx.doi.org/10.2459/JCM.0000000000000576] [PMID: 28937580]
[8]
Chiabrando JG, Bonaventura A, Vecchié A, et al. Management of acute and recurrent pericarditis: JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 75(1): 76-92.
[http://dx.doi.org/10.1016/j.jacc.2019.11.021] [PMID: 31918837]
[9]
Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the Colchicine for acute PEricarditis (COPE) trial. Circulation 2005; 112(13): 2012-6.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.542738] [PMID: 16186437]
[10]
Zöller B, Li X, Sundquist J, Sundquist K. Autoimmune diseases and venous thromboembolism: A review of the literature. Am J Cardiovasc Dis 2012; 2(3): 171-83.
[PMID: 22937487]
[11]
Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013; 369(16): 1522-8.
[http://dx.doi.org/10.1056/NEJMoa1208536] [PMID: 23992557]
[12]
Imazio M, Brucato A, Doria A, et al. Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and clinical significance. Int J Cardiol 2009; 136(3): 289-93.
[http://dx.doi.org/10.1016/j.ijcard.2008.05.020] [PMID: 18674829]
[13]
Marinella MA. Electrocardiographic manifestations and differential diagnosis of acute pericarditis. Am Fam Physician 1998; 57(4): 699-704.
[PMID: 9490993]
[14]
Persaud S, Singh B, Angelo D. An atypical etiology of acute pericarditis: A case report. Cureus 2021; 13(2): e13440.
[http://dx.doi.org/10.7759/cureus.13440] [PMID: 33763323]
[15]
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 2015; 28(1): 1-39.e14.
[http://dx.doi.org/10.1016/j.echo.2014.10.003] [PMID: 25559473]
[16]
Saricam E, Saglam Y, Hazirolan T. Clinical evaluation of myocardial involvement in acute myopericarditis in young adults. BMC Cardiovasc Disord 2017; 17(1): 129.
[http://dx.doi.org/10.1186/s12872-017-0564-8] [PMID: 28532506]
[17]
Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson 2009; 11(1): 14.
[http://dx.doi.org/10.1186/1532-429X-11-14] [PMID: 19413898]
[18]
Sarıçam E, Dursun AD, Türkmen Sarıyıldız G, et al. Laboratory and imaging evaluation of cardiac involvement in patients with post-acute COVID-19. Int J Gen Med 2021; 14: 4977-85.
[http://dx.doi.org/10.2147/IJGM.S321156] [PMID: 34511982]
[19]
Küçük A, Polat Y. , Kılıçarslan A, et al. Irisin protects against hind limb ischemia reperfusion injury. Drug Des Devel Ther 2021; 15: 361-8.
[http://dx.doi.org/10.2147/DDDT.S279318] [PMID: 33574655]
[20]
Voigt J, Krause C, Rohwäder E, et al. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol 2012; 2012: 1-7.
[http://dx.doi.org/10.1155/2012/651058] [PMID: 23251220]
[21]
Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014; 2014: 1-18.
[http://dx.doi.org/10.1155/2014/315179] [PMID: 24868563]
[22]
Op De Beeck K, Vermeersch P, Verschueren P, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011; 10(12): 801-8.
[http://dx.doi.org/10.1016/j.autrev.2011.06.005] [PMID: 21741497]
[23]
Laufer-Perl M, Havakuk O, Shacham Y, et al. Sex-based differences in prevalence and clinical presentation among pericarditis and myopericarditis patients. Am J Emerg Med 2017; 35(2): 201-5.
[http://dx.doi.org/10.1016/j.ajem.2016.10.039] [PMID: 27836311]
[24]
Lazaros G, Antonopoulos AS, Lazarou E, et al. Age‐ and sex‐based differences in patients with acute pericarditis. Eur J Clin Invest 2021; 51(3): e13392.
[http://dx.doi.org/10.1111/eci.13392] [PMID: 32857868]
[25]
Zöller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: A nationwide follow-up study from Sweden. Lancet 2012; 379(9812): 244-9.
[http://dx.doi.org/10.1016/S0140-6736(11)61306-8] [PMID: 22119579]
[26]
Martinelli I, Bucciarelli P, Mannucci PM. Thrombotic risk factors: Basic pathophysiology. Crit Care Med 2010; 38(2) (Suppl.): S3-9.
[http://dx.doi.org/10.1097/CCM.0b013e3181c9cbd9] [PMID: 20083911]
[27]
Palatinus A, Adams M. Thrombosis in systemic lupus erythematosus. Semin Thromb Hemost 2009; 35(7): 621-9.
[http://dx.doi.org/10.1055/s-0029-1242716] [PMID: 20013529]
[28]
Fabio F, Lykoudis P, Gordon P. Thromboembolism in inflammatory bowel disease: An insidious association requiring a high degree of vigilance. Semin Thromb Hemost 2011; 37(3): 220-5.
[http://dx.doi.org/10.1055/s-0031-1273086] [PMID: 21455856]
[29]
Matta F, Singala R, Yaekoub A, Najjar R, Stein P. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 2009; 101(1): 134-8.
[http://dx.doi.org/10.1160/TH08-08-0551] [PMID: 19132199]
[30]
Rastegar R, Harnick DJ, Weidemann P, et al. Spontaneous echo contrast videodensity isflow-related and is dependent on the relative concentrations of fibrinogen and red blood cells. J Am Coll Cardiol 2003; 41(4): 603-10.
[http://dx.doi.org/10.1016/S0735-1097(02)02898-X] [PMID: 12598072]
[31]
Yalavarthi S, Gould TJ, Rao AN, et al. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol 2015; 67(11): 2990-3003.
[http://dx.doi.org/10.1002/art.39247] [PMID: 26097119]
[32]
Vlachoyiannopoulos PG, Routsias JG. A novel mechanism of thrombosis in antiphospholipid antibody syndrome. J Autoimmun 2010; 35(3): 248-55.
[http://dx.doi.org/10.1016/j.jaut.2010.06.015] [PMID: 20638238]
[33]
Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in churg-strauss syndrome. Arthritis Rheum 2005; 52(9): 2926-35.
[http://dx.doi.org/10.1002/art.21250] [PMID: 16142760]
[34]
Natorska J. Celińska-Lowenhoff M, Undas A. High prevalence of antinuclear antibodies in patients following venous thromboembolism. Adv Clin Exp Med 2018; 27(6): 827-32.
[http://dx.doi.org/10.17219/acem/78361] [PMID: 29877639]

Rights & Permissions Print Cite
Article Metrics
29
2
© 2024 Bentham Science Publishers | Privacy Policy